Treatment of a severe vascular disease using a bespoke CRISPR–Cas9 base editor in mice
Christiano R. R. Alves(Harvard University), Patricia L. Musolino(Harvard University), Rachael K. Wood, Joana Ferreira da Silva(Harvard University), Leillani L. Ha(Massachusetts General Hospital), Jun Xie(Hainan University), Kangsan Roh(Harvard University), Nahye Kim(Harvard University), Hannah E. Stutzman(Massachusetts General Hospital), Vijai Krishnan(Massachusetts General Hospital), Mark E. Lindsay(Massachusetts General Hospital), Rachel A. Silverstein(Harvard University), Benjamin P. Kleinstiver(Harvard University), Lauren R. Fox(Massachusetts General Hospital), Casey A. Maguire(Harvard University), Pazhanichamy Kalailingam(National University of Singapore), Demitri de la Cruz(Harvard University), Luke H. Chao(Harvard University), Sabyasachi Das(Massachusetts General Hospital), Heather Gray‐Edwards(UMass Memorial Health Care), Friederike M. C. Benning(Harvard University), Rajeev Malhotra(Brigham and Women's Hospital), Shengdar Q. Tsai(Harvard University), Rashmi Richa(Harvard University), Siobhán McCarthy(Massachusetts General Hospital), Takahiko Imai(Harvard University), Joseph Lawton(Harvard University), C.K. Fong(Massachusetts General Hospital), Shuqi Yun(Massachusetts General Hospital), Christian L. Lino Cardenas(Harvard University), Claire E. Shamber(Massachusetts General Hospital), David Y. Chung(Harvard University)
Cited by 8
Related Papers
Efficient genome editing in zebrafish using a CRISPR-Cas system
|Nature Biotechnology|2013|3k
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
|Nature|2016|2.7k
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
|Nature Biotechnology|2014|2.3k
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
|Nature|2015|1.7k
Enhanced proofreading governs CRISPR–Cas9 targeting accuracy
|Nature|2017|1.2k